Literature DB >> 10754436

Colocalization of aldehyde dehydrogenases and Fe/NADPH-induced lipid peroxidation in tissue sections of rat retina.

M D Pinazo-Durán1, C Verdejo, I Azorín, J Renau-Piqueras, F J Iborra.   

Abstract

Epidemiological and experimental studies suggest the involvement of lipid peroxidation (LPO) in retinal diseases. Clinicians usually prescribe antioxidants to help in the treatment of proliferative diabetic vitreoretinopathy and age-related macular degeneration. In spite of this, these processes inexorably induce visual impairment and may progress towards blindness. In addition to other pathogenic mechanisms not fully understood, it may be that peroxidic aldehydes from LPO occurring in the eyes, acting as cytotoxic chemicals, mediate in these chronic disorders. To test the mechanisms of removing peroxidic aldehydes from retinal cells and in an attempt to understand long-lasting changes induced by LPO, the distribution and activity of aldehyde dehydrogenases (ALDH) in the rat retina were studied and compared with the LPO sites induced by iron/nicotine adenine dinucleotide phosphate. Histochemical and immunocytochemical assays revealed the colocalization of LPO and ALDH, mainly in the photoreceptors and inner retinal layers. This suggests the involvement of ALDH in detoxifying peroxidic aldehydes from the retina. Any change in ALDH retinal expression and distribution might be of crucial importance in assessing the paths of LPO-mediated vitreoretinopathies. Further research is needed to evaluate these findings and their application to new ophthalmic therapy. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754436     DOI: 10.1159/000055591

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  6 in total

Review 1.  Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for vision.

Authors:  Ying Chen; David C Thompson; Vindhya Koppaka; James V Jester; Vasilis Vasiliou
Journal:  Prog Retin Eye Res       Date:  2012-10-23       Impact factor: 21.198

2.  Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction.

Authors:  Guillermo Elizondo; Irma M Medina-Díaz; Raymundo Cruz; Frank J Gonzalez; Libia Vega
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

3.  REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia.

Authors:  Dulce Lima Cunha; Rose Richardson; Dhani Tracey-White; Alessandro Abbouda; Andreas Mitsios; Verena Horneffer-van der Sluis; Panteleimon Takis; Nicholas Owen; Jane Skinner; Ailsa A Welch; Mariya Moosajee
Journal:  JCI Insight       Date:  2021-05-10

Review 4.  Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?

Authors:  Andreea Ciudin; Cristina Hernández; Rafael Simó
Journal:  Exp Diabetes Res       Date:  2010-08-08

Review 5.  Oxidative stress and its downstream signaling in aging eyes.

Authors:  María Dolores Pinazo-Durán; Roberto Gallego-Pinazo; Jose Javier García-Medina; Vicente Zanón-Moreno; Carlo Nucci; Rosa Dolz-Marco; Sebastián Martínez-Castillo; Carmen Galbis-Estrada; Carla Marco-Ramírez; Maria Isabel López-Gálvez; David J Galarreta; Manuel Díaz-Llópis
Journal:  Clin Interv Aging       Date:  2014-04-11       Impact factor: 4.458

Review 6.  Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.

Authors:  Arnau Panisello-Roselló; Alexandre Lopez; Emma Folch-Puy; Teresa Carbonell; Anabela Rolo; Carlos Palmeira; René Adam; Marc Net; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.